Biography

Dr. Alireza Firooz

Center for Research and Training in Skin Diseases and Leprosy

Tehran University of Medical Sciences, Tehran

Email: [email protected]


Qualifications

1990 M.D., Tehran University of Medical Sciences, Tehran, Iran


Publications (Selected)

  1. Verma, S. B., Khurana, A., Bosshard, P. P., Kargl, A., Singal, A., Saraswat, A., ... & Nenoff, P. ‘Trichophyton indotineae’is an inaccurate and pejorative term. Indian Journal of Dermatology, Venereology and Leprology, 1-4.
  2. Kamali, M., Ghaderi, A., Tamimi, P., Firooz, A., Nasiri Kashani, M., Ayatollahi, A., ... & Fattahi, M. (2024). Reactive oxygen species-inducing itraconazole and its anti-biofilm activity against resistant Candida parapsilosis sensu lato biofilm cells isolated from patients with recalcitrant onychomycosis. Archives of Dermatological Research, 316(9), 642.
  3. Eskandari, S. E., Samadi, A., Kardeh, S., Dowlati, Y., Yazdi, H. A., & Firooz, A. (2024). Photobiomodulation Therapy for Improvement of Body Contour: A Retrospective Study on Middle Eastern Participants. Iranian Journal of Public Health, 53(8), 1858.
  4. Yazdanparast, T., Shamsipour, M., Ayatollahi, A., Delavar, S., Ahmadi, M., Samadi, A., & Firooz, A. (2024). Comparison of the Diagnostic Accuracy of Teledermoscopy, Face-to-Face Examinations and Artificial Intelligence in the Diagnosis of Melanoma. Indian Journal of Dermatology, 69(4), 296-300.
  5. Yazdanparast, T., Ahmad Nasrollahi, S., Samadi, A., Kafi, H., Nassiri Kashani, M., Ayatollahi, A., & Firooz, A. (2024). Safety and Efficacy Assessment of a Cross‐linked Hyaluronic Acid Dermal Filler for Correction of Moderate‐to‐Severe Nasolabial Folds in Skin Types III and IV. Dermatologic Therapy, 2024(1), 8487221.
  6. Samadi, A., Yazdi, H. A., Kafi, H., Yazdanparast, T., Nasrollahi, S. A., Zartab, H., & Firooz, A. (2025). Efficacy Evaluation of a Hyaluronic Acid Dermal Filler Containing Mannitol: Clinical and Aesthetic Assessment Using High-Frequency Ultrasound. Dermatologic Surgery, 51(1), 46-51.
  7. Tamimi, P., Fattahi, M., Ghaderi, A., Firooz, A., Shirvani, F., Alkhen, A., & Zamani, S. (2024). Terbinafin‐resistente Trichophyton indotineae mit F397L/L393S‐oder F397L/L393F‐Mutation bei Patienten mit Tinea incognita unter Glukokortikosteroiden. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(7), 922-935.
  8. Yazdanparast, T., Mohseni, A., Dehghan, K. S., Delavar, S., & Firooz, A. (2024). High‐frequency ultrasound evaluation of morphea: Retrospective analytical study. Skin Research and Technology, 30(7), e13818.
  9. Pakdaman, S. F., Samadi, A., Fattahi, M., Naeimifar, A., Ardehali, F. A., Ketabi, Y., ... & Firooz, A. (2024). Fabrication and efficacy assessment of combination of brimonidine and ivermectin for treatment of papulopustular rosacea. Journal of Cosmetic Dermatology, 23(9), 2973-2981.
  10. Ayatollahi, A., Samadi, A., Barikbin, B., Saeedi, M., Saeedi, L., Zamani, S., ... & Firooz, A. (2024). Efficacy and Tolerability of a Hyaluronic Acid-Based Extracellular Matrix for Labia Majora Rejuvenation and Augmentation: A Pilot Study. Cureus, 16(4).
  11. Ayatollahi, A., Firooz, A., Shakoei, S., Robati, R. M., Aramipour, N., Sadeghi, S., ... & Lashgari, N. A. (2024). Efficacy and Safety of Phoenix dactylifera L. Leaf Extract (WartOver®) in the Treatment of Cutaneous Warts: A Randomized, Double‐Blind, Placebo‐Controlled Trial. Dermatologic Therapy, 2024(1), 8814508.
  12. Amirzargar, B., Fattahi, M., Lotfali, E., Firooz, A., Mohammadi, A. M., & Khamesipoor, A. (2023). Isolation, Characterization, and Antifungal Sensitivity Pattern of Candida Species Causing Otomycosis. Acta Medica Iranica, 455-458.
  13. Zartab, H., Aflatoonian, M., Shamsi‐Meymandi, S., Pardakhty, A., Isazadeh, A., Firooz, A., & Amiri, R. (2024). Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non‐segmental vitiligo. Journal of Cosmetic Dermatology.
  14. Yazdanparast, T., Nassiri Kashani, M., Shamsipour, M., Izadi Heidari, F., Amiri, F., & Firooz, A. (2024). Contact allergens responsible for eyelid dermatitis in adults. The Journal of Dermatology, 51(5), 691-695.
  15. Ehsani, A., Firooz, A., Jahanshahi, A., Lajevardi, V., Mansouri, P., Kashani, M. N., ... & Saffarian, Z. (2023). Update of the diagnosis and treatment of urticaria: Iranian Society of Dermatology clinical practice guideline. Iranian Journal of Dermatology, 26(4), 163-184.
  16. Samadi, A., Rokhsat, E., Saffarian, Z., Goudarzi, M. M., Kardeh, S., Nasrollahi, S. A., & Firooz, A. (2024). Assessment of the efficacy and tolerability of a topical formulation containing caffeine and Procapil 3% for improvement of male pattern hair loss. Journal of Cosmetic Dermatology, 23(4).
  17. Samadi, A., Ayatollahi, A., Kashani, M. N., Zamani, S., & Firooz, A. (2024). Efficacy and tolerability assessment of a polynucleotide-based gel for improvement of pattern hair loss. Archives of Dermatological Research, 316(6), 331.
  18. Firooz, A., Zamani, S., Ghadrei, A., Ayatollahi, A., Tamimi, P., Khamesipour, A., ... & Fattahi, M. (2023). Evaluation of Efficacy and Safety of Topical Nanoliposomal Amphotericin B 0.4% Gel as a Potential Treatment for Onychomycosis: An Interventional Pilot Clinical Study. Dermatologic Therapy, 2023(1), 9955124.
  19. Ayatollahi, A., Aramipour, N., Sadri, A., Firooz, A., Robati, R. M., Fattahi, M., ... & Saber, M. (2022). Efficacy and safety of date palm leaf‐based ointment for treatment of cutaneous warts: a pilot clinical trial. Dermatologic Therapy, 35(12), e15968.
  20. Khamesipour, A., Mohammadi, A., Jaafari, M., Eskandari, S., Tasbihi, M., Javadi, A., ... & Firooz, A. (2022). Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran. East Mediterr Health J, 28(9).
  21. Naeimifar, A., Ahmad Nasrollahi, S., Samadi, A., Aryanian, Z., Akbari Javar, H., Rouini, M., ... & Firooz, A. (2022). Evaluation of tolerability and efficacy of a topical emulgel containing nanoliposomal ruxolitinib phosphate in the treatment of mild atopic dermatitis: A before-after single group pilot study. Journal of Dermatological Treatment, 33(8), 3160-3164.
  22. Noormohammadpour, P., Ehsani, A., Mahmoudi, H., Razavi, Z., Balighi, K., Azar, P. M., ... & Jabbari, A. (2022). Botulinum toxin injection as a single or combined treatment with non‐cross‐linked high molecular weight and low molecular weight hyaluronic acid gel for neck rejuvenation: A randomized clinical trial. Dermatologic therapy, 35(10), e15673.
  23. Samadi, A., Sartipi, Z., Ahmad Nasrollahi, S., Sheikholeslami, B., Nassiri Kashani, M., Rouini, M. R., ... & Firooz, A. (2022). Efficacy assessments of tretinoin-loaded nano lipid carriers in acne vulgaris: A double blind, split-face randomized clinical study. Archives of Dermatological Research, 314(6), 553-561.
  24. Khatami, A., Yazdanparast, T., Ahmad Nasrollahi, S., Miramin Mohammadi, A., Yadangi, S., Khamesipour, A., ... & Firooz, A. (2022). Biophysical and ultrasonographic changes of acute Old World cutaneous leishmaniasis skin lesions in comparison with uninvolved skin: A possible tool for non‐invasive early detection and treatment outcome assessment. Dermatologic Therapy, 35(9), e15699.
  25. Samadi, A., Ketabi, Y., Firooz, R., & Firooz, A. (2022). Efficacy of intramuscular injections of biotin and dexpanthenol in the treatment of diffuse hair loss: A randomized, double‐blind controlled study comparing two brands. Dermatologic Therapy, 35(9), e15695.


Profile Details

https://scholar.google.com/citations?hl=zh-CN&user=_ZI3r7wAAAAJ

https://www.researchgate.net/profile/Alireza-Firooz-2


SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top